Skip to content
OpenCapital
Get started

Alkermes ALKS PP&E Sale Proceeds

PP&E Sale Proceeds at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$19.6M—

Other financials

Income statement

See full
Revenue$392.9M+28.2%
Gross profit$331.3M+28.8%
Operating income-$48.3M-450%
Net income-$66.5M-396%
EPS (diluted)-$0.40-408%

Balance sheet

See full
Cash & equivalents$351.6M-12.1%
Total debt$1.6B+2,034%
Total equity$1.8B+15.9%
Total assets$4.3B+105%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$4.1M-59.5%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$7.5B+9.7%
Enterprise value$8.73B+41.2%
P/E49.1×+29.7×
P/S4.8×+0.3×

Profitability

See full
Gross margin86.6%+2.2pp
Operating margin12.3%-13.6pp
Net margin9.8%-13.5pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity9.4%-16.1pp
Debt / equity0.9×+0.9×
Current ratio2.3×-1.1×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment.

The official record: Alkermes’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alkermes's pp&e sale proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alkermes's PP&E sale proceeds?
Alkermes (ALKS) reported PP&E sale proceeds of $9K in Q1 2026.
How has Alkermes's PP&E sale proceeds changed year-over-year?
Alkermes's PP&E sale proceeds decreased by 99.5% year-over-year, from $1.71M to $9K.
What does PP&E sale proceeds mean?
Cash received from selling company assets like land, buildings, or machinery.
How do you interpret PP&E sale proceeds?
An increase can signal asset optimization or a strategic shift, providing a one-time boost to cash flow.
How does PP&E sale proceeds compare across companies?
Usually infrequent and non-recurring for most biotechnology firms.